Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

TMC125-C223: TMC125 in HIV-1 Infected Subjects

This study has been completed.
Sponsor:
Information provided by:
Tibotec Pharmaceuticals, Ireland
ClinicalTrials.gov Identifier:
NCT00081978
First received: April 28, 2004
Last updated: April 26, 2010
Last verified: April 2010